In that study, obese female MyMRKO mice showed improved insulin sensitivity and glucose homeostasis and lower liver steatosis as compared to FC and hepatocytes from MyMRKO mice were reported to exhibit downregulated expression of genes involved in lipogenesis and lipid storage, such as, SCD-1, Ly6d, and Cidea (29). The gene discussed is LY6D; the disease is digestive system neoplasm.